These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7498295)

  • 1. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635.
    Pike VW; McCarron JA; Lammerstma AA; Hume SP; Poole K; Grasby PM; Malizia A; Cliffe IA; Fletcher A; Bench CJ
    Eur J Pharmacol; 1995 Sep; 283(1-3):R1-3. PubMed ID: 7498295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635.
    Pike VW; McCarron JA; Lammertsma AA; Osman S; Hume SP; Sargent PA; Bench CJ; Cliffe IA; Fletcher A; Grasby PM
    Eur J Pharmacol; 1996 Apr; 301(1-3):R5-7. PubMed ID: 8773468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography.
    Mathis CA; Simpson NR; Mahmood K; Kinahan PE; Mintun MA
    Life Sci; 1994; 55(20):PL403-7. PubMed ID: 7968222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatives of WAY 100635 as potential imaging agents for 5-HT1A receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation.
    Wilson AA; Inaba T; Fischer N; Dixon LM; Nobrega J; DaSilva JN; Houle S
    Nucl Med Biol; 1998 Nov; 25(8):769-76. PubMed ID: 9863565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
    Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
    Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.
    Yasuno F; Zoghbi SS; McCarron JA; Hong J; Ichise M; Brown AK; Gladding RL; Bacher JD; Pike VW; Innis RB
    Synapse; 2006 Dec; 60(7):510-20. PubMed ID: 16952161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbal memory and 5-HT1A receptors in healthy volunteers--A PET study with [carbonyl-(11)C]WAY-100635.
    Penttilä J; Hirvonen J; Tuominen L; Lumme V; Ilonen T; Någren K; Hietala J
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):570-7. PubMed ID: 26775837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
    Farde L; Ginovart N; Ito H; Lundkvist C; Pike VW; McCarron JA; Halldin C
    Psychopharmacology (Berl); 1997 Sep; 133(2):196-202. PubMed ID: 9342787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans.
    Rabiner EA; Wilkins MR; Turkheimer F; Gunn RN; Udo de Haes J; de Vries M; Grasby PM
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1144-50. PubMed ID: 12023549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
    Laporte AM; Lima L; Gozlan H; Hamon M
    Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.